Ruchi Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ruchi Sharma has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Kapil Bharti
Ocular and Stem Cell Translational Research Section, National Eye Institute, NIH
4 shared publications - Arvydas Maminishkis
National Eye Institute (NEI)/Translational Research Core/Ophthalmic Genetics and Visual Function Branch (OGVFB), Bethesda, Maryland, USA
2 shared publications - Balendu Shekhar Jha
Ocular and Stem Cell Translational Research Section, National Eye Institute, National Institutes of Health, Bethesda, USA
2 shared publications Qin Wan
Section on Epithelial and Retinal Physiology and Disease, National Eye Institute, NIH, Bethesda, MD 20892, USA
2 shared publications- Aaron Rising
Kentucky Spinal Cord Injury Research Center Department of Neurological Surgery University of Louisville Louisville KY USA
1 shared publication - Alexander J. Choi
North Texas Eye Research Institute, University of North Texas Health Science Center, 3430 Camp Bowie Blvd, Fort Worth, TX 76107, USA
1 shared publication
Latest Publications
- Open Access
- 29 October 2026
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 115
3D corneal and retinal bioprinting: Tissue engineering strategies, translational challenges, and clinical opportunities
- 29 October 2026
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 115
Open Access3D corneal and retinal bioprinting: Tissue engineering strategies, translational challenges, and clinical opportunities
- Top Cited Papers
- 16 January 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (475)
Clinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs
A retinal pigment epithelial patch derived from mutation-free pluripotent stem cells shows therapeutic effects in rats and pigs.
- 16 January 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (475)
Top Cited PapersClinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs
A retinal pigment epithelial patch derived from mutation-free pluripotent stem cells shows therapeutic effects in rats and pigs.
- 21 December 2017
- Published by Springer Nature
- Vol. 1722, 223-247
Polarized Human Retinal Pigment Epithelium Exhibits Distinct Surface Proteome on Apical and Basal Plasma Membranes
Surface proteins localized on the apical and basal plasma membranes are required for a cell to sense its environment and relay changes in ionic, cytokine, chemokine, and hormone levels to the inside of the cell. In a polarized cell, surface proteins are differentially localized on the apical or the basolateral sides of the cell. The retinal pigment epithelium (RPE) is an example of a polarized cell that performs a variety of functions that are dependent on its polarized state including trafficking of ions, fluid, and metabolites across the RPE monolayer. These functions are absolutely crucial for maintaining the health and integrity of adjacent photoreceptors, the photosensitive cells of the retina. Here we present a series of approaches to identify and validate the polarization state of cultured primary human RPE cells using immunostaining for RPE apical/basolateral markers, polarized cytokine secretion, electrophysiology, fluid transport, phagocytosis, and identification of plasma membrane proteins through cell surface capturing technology. These approaches are currently being used to validate the polarized state and the epithelial phenotype of human induced pluripotent stem (iPS) cell derived RPE cells. This work provides the basis for developing an autologous cell therapy for age-related macular degeneration using patient specific iPS cell derived RPE. Key words Retinal pigment epithelium Polarization Monolayer Immunocytochemistry Cytokine secretion Electrophysiology Fluid transport Phagocytosis Cell surface capturing
- 21 December 2017
- Published by Springer Nature
- Vol. 1722, 223-247
Polarized Human Retinal Pigment Epithelium Exhibits Distinct Surface Proteome on Apical and Basal Plasma Membranes
Surface proteins localized on the apical and basal plasma membranes are required for a cell to sense its environment and relay changes in ionic, cytokine, chemokine, and hormone levels to the inside of the cell. In a polarized cell, surface proteins are differentially localized on the apical or the basolateral sides of the cell. The retinal pigment epithelium (RPE) is an example of a polarized cell that performs a variety of functions that are dependent on its polarized state including trafficking of ions, fluid, and metabolites across the RPE monolayer. These functions are absolutely crucial for maintaining the health and integrity of adjacent photoreceptors, the photosensitive cells of the retina. Here we present a series of approaches to identify and validate the polarization state of cultured primary human RPE cells using immunostaining for RPE apical/basolateral markers, polarized cytokine secretion, electrophysiology, fluid transport, phagocytosis, and identification of plasma membrane proteins through cell surface capturing technology. These approaches are currently being used to validate the polarized state and the epithelial phenotype of human induced pluripotent stem (iPS) cell derived RPE cells. This work provides the basis for developing an autologous cell therapy for age-related macular degeneration using patient specific iPS cell derived RPE. Key words Retinal pigment epithelium Polarization Monolayer Immunocytochemistry Cytokine secretion Electrophysiology Fluid transport Phagocytosis Cell surface capturing
- 7 April 2017
- Published by Taylor & Francis
- p. 195-230
Induced Pluripotent Stem Cells: A Research Tool and a Potential Therapy for RPE-Associated Blinding Eye Diseases
- 7 April 2017
- Published by Taylor & Francis
- p. 195-230
Induced Pluripotent Stem Cells: A Research Tool and a Potential Therapy for RPE-Associated Blinding Eye Diseases
- Open Access
- 1 May 2012
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 31 (5) , 721-731
Cloning and Characterization of Buffalo NANOG Gene: Alternative Transcription Start Sites, Splicing, and Polyadenylation in Embryonic Stem Cell-Like Cells
NANOG is a critical homeodomain transcription factor responsible for maintaining embryonic stem cell (ESC) self-renewal and pluripotency. In the present study, we isolated, sequenced, and characterized the NANOG gene in buffalo ESC-like cells. Here, we demonstrated that NANOG mRNA is expressed as multiple isoforms and uses four alternative transcriptional start sites (TSSs) and five different polyadenylation sites. The TSSs identified by 5′-RNA ligase-mediated rapid amplification of cDNA ends (RLM-5′-RACE) were positioned at 182, 95, 35, and 17 nucleotides upstream relative to the translation initiation codon. 3′-RACE experiment revealed the presence of tandem polyadenylation signals, which leads to the expression of at least five different 3′-untranslated regions (269, 314, 560, 566, and 829 nucleotides). Expression analysis showed that these alternatively polyadenylated transcripts expressed differentially. Sequence analysis showed that the open reading frame of buffalo NANOG codes for a 300-amino-acid-long protein. Further, results showed that alternative splicing leads to the expression of two types of transcript variants encoded by four and five exons. In silico analysis of cloned 5′-flanking region (3366 nucleotides upstream of translation start codon) identified several putative transcription factors binding sites in addition to a TATA box and CAAT box at −30 and −139 bp (upstream to the distal most TSS), respectively, in the buffalo NANOG promoter.
- 1 May 2012
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 31 (5) , 721-731
Open AccessCloning and Characterization of Buffalo NANOG Gene: Alternative Transcription Start Sites, Splicing, and Polyadenylation in Embryonic Stem Cell-Like Cells
NANOG is a critical homeodomain transcription factor responsible for maintaining embryonic stem cell (ESC) self-renewal and pluripotency. In the present study, we isolated, sequenced, and characterized the NANOG gene in buffalo ESC-like cells. Here, we demonstrated that NANOG mRNA is expressed as multiple isoforms and uses four alternative transcriptional start sites (TSSs) and five different polyadenylation sites. The TSSs identified by 5′-RNA ligase-mediated rapid amplification of cDNA ends (RLM-5′-RACE) were positioned at 182, 95, 35, and 17 nucleotides upstream relative to the translation initiation codon. 3′-RACE experiment revealed the presence of tandem polyadenylation signals, which leads to the expression of at least five different 3′-untranslated regions (269, 314, 560, 566, and 829 nucleotides). Expression analysis showed that these alternatively polyadenylated transcripts expressed differentially. Sequence analysis showed that the open reading frame of buffalo NANOG codes for a 300-amino-acid-long protein. Further, results showed that alternative splicing leads to the expression of two types of transcript variants encoded by four and five exons. In silico analysis of cloned 5′-flanking region (3366 nucleotides upstream of translation start codon) identified several putative transcription factors binding sites in addition to a TATA box and CAAT box at −30 and −139 bp (upstream to the distal most TSS), respectively, in the buffalo NANOG promoter.